Visakorpi, T.

cancer prostate patient prostate cancer trial study phase expression docetaxel protein metastatic progression factor tmprs receptor fusion erg protein expression japanese clinicaltrials.gov identifier androgen therapy group effect treatment growth pathology disease level randomised cohort oncol erg expression response pathol clusterin antigen activity combination metastatic crpc prednisone phase 2 trial european inhibitor chemotherapy family agent antibody result identifier clinicaltrials.gov specimen tissue castration model urology decline placebo japanese pca patients survival mechanism apoptosi urological pathology consensus conference hormone-refractory society detection hormone atrasentan endpoint immunotherapy localised castration-resistant prostate cancer hormone-refractory prostate cancer zoledronic acid phase 1 trials metastase prostatectomy specimens 594–605 ctla -4 blockade placebo-controlled trial